Abbott Laboratories

125.27
-6.36 (-4.83%)
At close: Apr 04, 2025, 3:44 PM

Abbott Laboratories Revenue Breakdown

Quarter Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jun 30, 2016Mar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015Dec 31, 2014Sep 30, 2014Jun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013Jun 30, 2013Mar 31, 2013Dec 31, 2012Sep 30, 2012Jun 30, 2012Mar 31, 2012Dec 31, 2011Sep 30, 2011
Diagnostic Products Revenue 0 5.3B 4.8B 4.5B 0 4.2B 4.2B 4.1B 3.5B 3.9B 3.9B 5.29B 3.82B 3.91B 3.9B 4.01B 305M 3.6B 3.5B 3.4B 0 3.2B 3.1B 3B 0 2.8B 2.8B 2.9B 1.91B 1.28B 1.27B 1.16B 1.26B 1.21B 1.23B 1.12B 1.22B 1.16B 1.18B 1.09B 1.24B 1.18B 1.19B 1.12B 1.2B 1.13B 1.14B 1.09B 1.13B 1.04B 1.08B 1.04B 3.1B 1.02B
Diagnostic Products Revenue Growth -100.00% +10.42% +6.67% n/a -100.00% 0.00% +2.44% +17.21% -10.31% 0.00% -26.22% +38.45% -2.40% +0.31% -2.84% +1216.07% -91.53% +2.86% +2.94% n/a -100.00% +3.23% +3.33% n/a -100.00% 0.00% -3.45% +52.15% +49.02% +0.47% +9.93% -7.80% +3.54% -1.06% +9.66% -8.36% +5.54% -1.78% +7.69% -11.50% +4.66% -0.76% +6.45% -6.68% +6.40% -0.88% +4.32% -3.72% +8.45% -3.34% +3.45% -66.40% +202.54% n/a
Established Pharmaceutical Products Revenue 1.27B 1.41B 1.29B 1.23B 1.22B 1.37B 1.29B 1.19B 2.44B 1.33B 436M 1.15B 1.2B 1.26B 1.18B 1.07B 1.15B 1.1B 1.01B 1.04B 1.17B 1.21B 1.11B 992M 1.09B 1.16B 1.13B 1.04B 1.15B 1.17B 1.02B 950M 979M 1.01B 980M 888M 885M 961M 977M 897M 922M 771M 1.22B 1.15B 1.29B 1.24B 1.22B 1.23B 6.49B 5.69B 5.63B 5.33B 16.75B 5.69B
Established Pharmaceutical Products Revenue Growth -9.82% +8.66% +5.55% +0.33% -10.67% +6.29% +8.24% -51.25% +83.94% +204.13% -61.99% -4.66% -4.90% +7.20% +10.28% -6.71% +4.37% +8.49% -2.97% -11.07% -3.14% +9.39% +11.69% -8.99% -5.95% +2.66% +8.14% -8.82% -2.22% +14.69% +7.47% -2.96% -3.26% +3.27% +10.36% +0.34% -7.91% -1.64% +8.92% -2.71% +19.58% -36.60% +5.65% -10.64% +4.29% +1.40% -1.22% -81.00% +14.02% +1.14% +5.57% -68.18% +194.50% n/a
Medical Devices Revenue 5.05B 4.75B 4.73B 4.45B 4.44B 4.25B 4.29B 3.9B 7.07B 3.62B n/a 3.56B 3.75B 3.63B 3.67B 3.32B 5.79B 3.17B 2.42B 400M 1.87B 1.87B 1.88B 1.79B 1.78B 1.84B 1.86B 1.76B 1.78B 1.77B 1.73B 1.64B 1.73B 1.75B 1.74B 1.67B 1.8B 1.79B 1.72B 1.67B 1.8B 1.79B 1.73B 1.63B 1.7B 1.64B 1.7B 1.7B 1.72B 1.6B 1.58B 1.57B 4.47B 1.54B
Medical Devices Revenue Growth +6.43% +0.27% +6.31% +0.23% +4.57% -1.07% +10.13% -44.85% +95.60% n/a n/a -4.91% +3.22% -0.93% +10.42% -42.70% +82.78% +30.83% +505.75% -78.59% -0.32% -0.05% +4.63% +0.84% -3.32% -1.08% +5.81% -1.57% +0.90% +2.14% +5.42% -5.25% -1.25% +0.86% +4.13% -7.17% +0.61% +4.19% +2.88% -7.48% +0.95% +3.24% +6.13% -4.17% +4.10% -4.05% +0.29% -0.99% +6.92% +1.33% +1.15% -64.96% +190.76% n/a
Nutritional Products Revenue 2.13B 2.07B 2.15B 2.07B 2.04B 2.07B 2.08B 1.97B 3.77B 1.79B n/a 1.89B 2.04B 2.11B 2.11B 2.04B 1.94B 1.92B 1.88B 1.9B n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Nutritional Products Revenue Growth +3.05% -3.91% +3.97% +1.47% -1.69% -0.14% +5.54% -47.82% +110.03% n/a n/a -7.25% -3.13% 0.00% +3.54% +5.17% +0.62% +2.18% -1.10% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a

Revenue by Geography

Quarter Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2013Dec 31, 2012Dec 31, 2011Dec 31, 2010
Non-Us Revenue 14.85B 14.08B 14.84B 15.52B 12.58B 3.41B 3.32B 1.07B 1.74B 1.76B 8.75B
Non-Us Revenue Growth +5.41% -5.10% -4.34% +23.33% +268.48% +2.96% +209.91% -38.51% -1.08% -79.90% n/a
C [H] Revenue 2.11B 2.25B 2.13B 2.57B n/a 1.75B 1.62B 922M 933M 2.34B 1.85B
C [H] Revenue Growth -6.21% +5.63% -17.07% n/a n/a +8.15% +75.60% -1.18% -60.16% +26.87% n/a
Germany Revenue 2.54B 2.35B 2.34B 1.7B n/a 1.4B 1.33B 1.44B 2.44B 2.11B 2.02B
Germany Revenue Growth +8.27% +0.21% +38.05% n/a n/a +4.80% -7.56% -40.93% +15.80% +4.10% n/a
India Revenue 1.82B 1.75B 1.65B n/a n/a 1.44B 1.33B 960M 1.88B 11.01B 2B
India Revenue Growth +3.83% +6.12% n/a n/a n/a +8.22% +38.12% -49.02% -82.90% +450.22% n/a
Japan Revenue 1.44B 1.51B 1.93B n/a n/a 975M 930M 5.28B 10.55B 16.01B 15.19B
Japan Revenue Growth -4.76% -21.69% n/a n/a n/a +4.84% -82.40% -49.95% -34.09% +5.40% n/a
Netherlands Revenue 1.12B 1.07B 1.34B n/a n/a 11.53B 11.21B 792M 16.78B n/a n/a
Netherlands Revenue Growth +4.66% -19.61% n/a n/a n/a +2.84% +1316.04% -95.28% n/a n/a n/a
Switzerland Revenue 1.75B 1.64B 18.14B n/a n/a n/a n/a 6.27B n/a n/a n/a
Switzerland Revenue Growth +6.65% -90.97% n/a n/a n/a n/a n/a n/a n/a n/a n/a
United States Revenue 16.32B 15.45B n/a n/a n/a n/a n/a n/a n/a n/a n/a
United States Revenue Growth +5.64% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a

Operating Expense Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jun 30, 2016Mar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
Selling, General, and Administrative Revenue 2.9B 2.92B 2.94B 2.7B 2.6B 2.62B 2.62B 2.97B 2.73B 2.76B 2.79B 3.05B 2.77B 2.73B 2.78B 2.57B 2.3B 2.28B 2.55B 2.41B 2.44B 2.43B 2.48B 2.36B 2.38B 2.47B 2.54B 2.46B 2.1B 2.13B 2.42B 1.61B 1.63B 1.74B 1.7B 1.66B 1.67B 1.73B 1.74B
Selling, General, and Administrative Revenue Growth -0.69% -0.95% +8.84% +3.96% -0.69% +0.15% -12.04% +8.86% -0.94% -1.08% -8.56% +10.16% +1.50% -2.05% +8.29% +11.64% +1.14% -10.68% +5.59% -1.11% +0.25% -1.78% +5.04% -0.76% -3.61% -2.99% +3.25% +17.29% -1.55% -12.05% +50.65% -1.17% -6.28% +2.30% +2.60% -0.66% -3.53% -0.58% n/a
Research and Development Revenue 713M 698M 679M 690M 672M 715M 654M 725M 782M 684M 697M 762M 672M 654M 654M 698M 580M 564M 578M 595M 596M 577M 672M 562M 574M 575M 589M 613M 562M 513M 547M 343M 352M 348M 379M 369M 378M 345M 313M
Research and Development Revenue Growth +2.15% +2.80% -1.59% +2.68% -6.01% +9.33% -9.79% -7.29% +14.33% -1.87% -8.53% +13.39% +2.75% n/a -6.30% +20.34% +2.84% -2.42% -2.86% -0.17% +3.29% -14.14% +19.57% -2.09% -0.17% -2.38% -3.92% +9.07% +9.55% -6.22% +59.48% -2.56% +1.15% -8.18% +2.71% -2.38% +9.57% +10.22% n/a